BIOL(Delisted)
Biolase·NASDAQ
--
--(--)
BIOL fundamentals
Biolase (BIOL) released its earnings on Mar 14, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Mar 14, 2018
EPS
Revenue
Revenue & Expenses
BIOL has released its 2024 Q1 earnings report, with revenue of 10.13M, reflecting a YoY change of -3.21%, and net profit of -6.49M, showing a YoY change of -10.87%. The Sankey diagram below clearly presents BIOL's revenue sources and cost distribution.
Key Indicators
Biolase (BIOL) key financial stats and ratios, covering profitability, financial health, and leverage.
Biolase (BIOL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Biolase (BIOL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Biolase (BIOL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Biolase (BIOL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Biolase (BIOL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
